TEs signature
presence of LSC
identification of LSC
LSC-specific signature
LSC exclusive targeting
TEs expression homology
AML biomarkers
project
Relapsed AML patients
human acute myeloid leukemia Acute myeloid leukemia
comprehensive characterization of TEs transcriptome
signature of transposable elements-derived transcripts
gene-derived transcriptome
better subclassification of AML samples
acute leukemias
derived oncoproteins exclusive
presence of leukemia stem cells
better categorization of patients
aberrant hematopoietic process
development of TE
human genome
existence of TE
normal progenitors
ideal background
ideal tool
gene regulation
cancer epigenetics
present proposal
CD38- cells
reprogramming process
malignant hematopoietic precursors
researcher
denser coverage of chromosomes
basis
soft skills
throughput sequencing
new collaborations
achievement
cell fractions
transposcriptome
excellence of European science
industry
impact
analytical pipelines
networks
important roles
advent of high
lack of proper technologies
pluripotency
accomplishment
adults
thirds
recent studies
effective therapies
expected result
academy
CD34
mediocre outcome
tumorigenesis